Pharmaceutical compositions containing famotidine and aluminum hydroxide or magnesium hydroxide
AssigneeMcNeil-PPC, Inc.
InventorsEdward John Roche, Susan Decoteau, Eleanor Freeman
Life of this patent
Estimating the term…
Abstract
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of a therapeutically effective amount of guanidinothiazole compound; and a therapeutically effective amount of an antacid wherein the pharmaceutical and an antacid are separated by a barrier which is substantially impermeable to an antacid.
Claims7
A solid oral dosage form for the treatment of gastrointestinal disorders comprising a therapeutically effective amount of impermeably coated famotidine granules for the treatment of gastric disorders and pharmacologically acceptable salts thereof;
- and a therapeutically effective amount of aluminum hydroxide or magnesium hydroxide wherein the oral dosage form has said coated famotidine granules and the aluminum hydroxide or magnesium hydroxide in contact with each other, but separated by said impermeable coating on the famotidine granules which is impermeable to the aluminum hydroxide or magnesium hydroxide.
A method for manufacturing a solid oral dosage form comprising:
- a) forming granules containing famotidine for the treatment of gastric disorder;
- b) coating the granules with a coating impermeable to aluminum hydroxide or magnesium hydroxide to form impermeably coated famotidine granules;
- c) mixing a therapeutically effective amount of aluminum hydroxide or magnesium hydroxide with a therapeutically effective amount of impermeably coated famotidine granules and pharmaceutically acceptable excipients to form a compression mixture;
- then d) pressing the compression mixture to form a solid oral dosage form.
Dependencies are inferred from the claim text.